SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-018460
Filing Date
2019-05-10
Accepted
2019-05-10 14:50:37
Documents
97
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q reph-10q_20190331.htm 10-Q 2068468
2 EX-31.1 reph-ex311_6.htm EX-31.1 17244
3 EX-31.2 reph-ex312_8.htm EX-31.2 17254
4 EX-32.1 reph-ex321_7.htm EX-32.1 8203
  Complete submission text file 0001564590-19-018460.txt   9789794

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT reph-20190331.xml EX-101.INS 2306593
6 XBRL TAXONOMY EXTENSION SCHEMA reph-20190331.xsd EX-101.SCH 82660
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE reph-20190331_cal.xml EX-101.CAL 73819
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE reph-20190331_def.xml EX-101.DEF 278952
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE reph-20190331_lab.xml EX-101.LAB 621631
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reph-20190331_pre.xml EX-101.PRE 485469
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36329 | Film No.: 19814391
SIC: 2834 Pharmaceutical Preparations